3CC-23760-67473 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-22
Dose 1 — Pfizer-BioNTech
2022-06-23
Registered in v-safe
2022-06-23
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-29
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-06
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-13
Dose 2 — Pfizer-BioNTech
2022-07-13
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-14
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: No adverse event — Feeling: Good · Site: Redness · Diarrhea

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-07-15
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: No adverse event — Feeling: Good · Diarrhea

Free text: No

MedDRA releases: 2024-11 · check-in free text available
2022-07-16
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Nasopharyngitis — Feeling: Fair · Diarrhea, Rash, not including the immediate area around the injection site

Free text: Possible head cold

MedDRA releases: 2024-11 · check-in free text available
2022-07-17
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-07-18
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-07-20
Survey response — day 7, dose 2, under 3
MedDRA: Rhinorrhoea — Feeling: Fair

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-07-27
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-03
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-10
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-17
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-24
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-12
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-11
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-22	Pfizer-BioNTech	No
2	2022-07-13	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-14

Systemic reaction (other): No

2022-07-15

Systemic reaction (other): No

2022-07-16

Systemic reaction (other): Possible head cold

2022-07-17

Systemic reaction (other): Runny nose

2022-07-18

Systemic reaction (other): Runny nose

Release 12 (Under 3) — day 7, dose 2, under 3

2022-07-20

Systemic reaction (other): Runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Nasopharyngitis	·	·	✓
SRO	No adverse event	·	·	✓
SRO	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release